Retraction Note: Anti-fibrotic mechanism of SPP1 knockdown in atrial fibrosis associates with inhibited mitochondrial DNA damage and TGF-β/SREBP2/PCSK9 signaling

Retraction Note: Anti-fibrotic mechanism of SPP1 knockdown in atrial fibrosis associates with inhibited mitochondrial DNA damage and TGF-β/SREBP2/PCSK9 signaling

Bibliographic Details
Main Authors:	Xianfeng Du, Ting Liu, Caijie Shen, Bin He, Mingjun Feng, Jing Liu, Weidong Zhuo, Guohua Fu, Binhao Wang, Yanyan Xu, Huimin Chu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-06-01
Series:	Cell Death Discovery
Online Access:	https://doi.org/10.1038/s41420-023-01516-9

Similar Items

RETRACTED ARTICLE: Anti-fibrotic mechanism of SPP1 knockdown in atrial fibrosis associates with inhibited mitochondrial DNA damage and TGF-β/SREBP2/PCSK9 signaling
by: Xianfeng Du, et al.
Published: (2022-05-01)

Left atrial appendage closure with zero fluoroscopic exposure via intracardiac echocardiographic guidance
by: Huimin Chu, et al.
Published: (2020-11-01)

The impact of empirical Marshall vein ethanol infusion as a first-choice intraoperative strategy on the long-term outcomes in patients with persistent atrial fibrillation undergoing mitral isthmus ablation
by: Xianfeng Du, et al.
Published: (2023-08-01)

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device
by: Guohua Fu, et al.
Published: (2022-08-01)

Delayed pericardial effusion or tamponade following left atrial appendage closure: A single-center experience
by: Guohua Fu, et al.
Published: (2023-08-01)

Safety and Efficacy of Left Atrial Catheter Ablation in Patients with Left Atrial Appendage Occlusion Devices
by: Binhao Wang, et al.
Published: (2022-05-01)

Unipolar Electrogram-Guided versus Lesion Size Index-Guided Catheter Ablation in Patients with Paroxysmal Atrial Fibrillation
by: Guohua Fu, et al.
Published: (2022-07-01)

Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance
by: Paul F. Lebeau, et al.
Published: (2022-02-01)

Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway
by: Jiyi Liang, et al.
Published: (2022-04-01)

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
by: Liwen Zhang, Timothy McCabe, Jon H. Condra, Yan G. Ni, Laurence B. Peterson, Weirong Wang, Alison M. Strack, Fubao Wang, Shilpa Pandit, Holly Hammond, Dana Wood, Dale Lewis, Ray Rosa, Vivienne Mendoza, Anne Marie Cumiskey, Douglas G. Johns, Barbara C. Han
Published: (2012-01-01)

Serum sdLDL-C and cellular SREBP2-dependent cholesterol levels: Is there a challenge on targeting PCSK9?
by: Soltanmohammadi Elham, et al.
Published: (2016-01-01)

Novel ASO therapeutic target designed against hyperlipidemia via PCSK9 knockdown
by: Xinjian Yu, et al.
Published: (2024-01-01)

Left Atrial Spontaneous Echo Contrast and Ischemic Stroke in Patients Undergoing Percutaneous Left Atrial Appendage Closure
by: Binhao Wang, et al.
Published: (2021-09-01)

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
by: Fan Jiang, et al.
Published: (2014-01-01)

Lipid regulation of protocatechualdehyde and hydroxysafflor yellow A via AMPK/SREBP2/PCSK9/LDLR signaling pathway in hyperlipidemic zebrafish
by: Bingying Lin, et al.
Published: (2024-02-01)

Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice[S]
by: Vikram Ravindra Shende, et al.
Published: (2015-04-01)

Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β–ERK5 Interaction
by: Kotaro Kadoya, et al.
Published: (2019-04-01)

Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
by: Bin Dong, et al.
Published: (2010-06-01)

SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression[S]
by: Laurent Vergnes, et al.
Published: (2016-03-01)

Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device
by: Yibo Yu, et al.
Published: (2023-06-01)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
by: Arnela Saljic, et al.
Published: (2022-07-01)

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
by: Nian Yang, et al.
Published: (2019-06-01)

Activation of TRPA1 in Bladder Suburothelial Myofibroblasts Counteracts TGF-β1-Induced Fibrotic Changes
by: Mengmeng Zhao, et al.
Published: (2023-05-01)

Resveratrol inhibits TGF-β1–induced fibrotic effects in human pterygium fibroblasts
by: Jianwu Fan, et al.
Published: (2023-10-01)

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy
by: Paul G. Thomes, et al.
Published: (2017-02-01)

Key events in cancer: Dysregulation of SREBPs
by: Yunkuo Li, et al.
Published: (2023-03-01)

The Effect of TGFβ1 in Adipocyte on Inflammatory and Fibrotic Markers at Different Stages of Adipocyte Differentiation
by: Babu Raja Maharjan, et al.
Published: (2022-11-01)

The roles and mechanisms of SREBP1 in cancer development and drug response
by: Ying He, et al.
Published: (2024-07-01)

Retraction of the paper: "Niemann-Pick type C1 protein influences the delivery of cholesterol to the SREBP:SCAP complex"
by: Yong-Jun Guo, et al.
Published: (2008-05-01)

RETRACTED ARTICLE: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
by: Amir Abbas Momtazi-Borojeni, et al.
Published: (2019-12-01)

Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
by: Amir Abbas Momtazi-Borojeni, et al.
Published: (2023-05-01)

SREBP-2, a new target of metformin?
by: Zhang F, et al.
Published: (2018-12-01)

Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes
by: Beáta Szebeni, et al.
Published: (2024-03-01)

Anti-fibrotic effects of tannic acid through regulation of a sustained TGF-beta receptor signaling
by: Eleanor B. Reed, et al.
Published: (2019-07-01)

Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis
by: Jung-Yeon Kim, et al.
Published: (2017-09-01)

The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney
by: Craig E. Higgins, et al.
Published: (2021-07-01)

The Prognostic Nutritional Index May Predict Left Atrial Appendage Thrombus or Dense Spontaneous Echo Contrast in Patients With Atrial Fibrillation
by: Zhao Wang, et al.
Published: (2022-04-01)

The Cholesterol-Lowering Effect of Capsella Bursa-Pastoris Is Mediated via SREBP2 and HNF-1α-Regulated PCSK9 Inhibition in Obese Mice and HepG2 Cells
by: Jin-Taek Hwang, et al.
Published: (2021-02-01)

Fermented Rhus Verniciflua Stokes Extract Alleviates Nonalcoholic Fatty Liver through the AMPK/SREBP1/PCSK9 Pathway in HFD-Induced Nonalcoholic Fatty Liver Animal Model
by: Seon-Ok Lee, et al.
Published: (2020-09-01)

Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma
by: Lulu Xie, et al.
Published: (2023-03-01)